640.7K
XNAS Volume
High volume+loss today
XNAS 01 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| William G. Rice | Director, Chair, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 25 Nov 2024 | 100,000 | 613,252 (0%) | 0% | 0.2 | 20,000 | Common Shares |
| William G. Rice | Director, Chair, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2024 | 50,000 | 50,000 | - | - | Warrants | |
| Vincent Mark D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Option (Right to Buy) | |
| Rice G. William | Director, Chair, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Erich M. Platzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Option (Right to Buy) | |
| Bernd Seizinger R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Option (Right to Buy) | |
| Warren Whitehead | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Options (Right to Buy) | |
| Philippe Ledru | Sr VP & Ch Commerical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 11,000 | 11,000 | - | - | Employee Stock Option (Right to Buy) | |
| Denis R. Burger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Option (Right to Buy) | |
| Carol Gail Ashe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Option (Right to Buy) | |
| Rafael Bejar | Sr VP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 35,000 | 35,000 | - | - | Employee Stock Option (Right to Buy) | |
| Fletcher Payne | Sr VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 55,000 | 55,000 | - | - | Employee Stock Option (Right to Buy) |